Vivos Therapeutics Inc
NASDAQ:VVOS
Vivos Therapeutics Inc
Gross Profit
Vivos Therapeutics Inc
Gross Profit Peer Comparison
Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors
Company | Gross Profit | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Vivos Therapeutics Inc
NASDAQ:VVOS
|
Gross Profit
$8.3m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
25%
|
CAGR 10-Years
N/A
|
|
DaVita Inc
NYSE:DVA
|
Gross Profit
$4B
|
CAGR 3-Years
4%
|
CAGR 5-Years
5%
|
CAGR 10-Years
1%
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Gross Profit
$3.1B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
3%
|
CAGR 10-Years
1%
|
|
CVS Health Corp
NYSE:CVS
|
Gross Profit
$53.6B
|
CAGR 3-Years
-20%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
8%
|
|
Cigna Corp
NYSE:CI
|
Gross Profit
$25.5B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Gross Profit
$3.4B
|
CAGR 3-Years
-16%
|
CAGR 5-Years
1%
|
CAGR 10-Years
5%
|
See Also
What is Vivos Therapeutics Inc's Gross Profit?
Gross Profit
8.3m
USD
Based on the financial report for Dec 31, 2023, Vivos Therapeutics Inc's Gross Profit amounts to 8.3m USD.
What is Vivos Therapeutics Inc's Gross Profit growth rate?
Gross Profit CAGR 5Y
25%
Over the last year, the Gross Profit growth was -17%. The average annual Gross Profit growth rates for Vivos Therapeutics Inc have been -7% over the past three years , 25% over the past five years .